UPDATE 3-FDA names drugmakers potentially acting to delay cheap generics
May 17, 2018 at 14:24 PM EDT
May 17 (Reuters) - The U.S. Food and Drug Administration on Thursday named a number of drugmakers it said could be improperly blocking access to their medicines in order to delay generic competition.